The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...

CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...

Updated Data from 31 Adult and Adolescent SCD Patients Treated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Many abstracts about myeloma being presented at ASH 2025 were also presented at the International Myeloma Society (IMS) ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

The main difference between its operations and the planned Fort Worth dispensary is the on-site medical marijuana storage.

A CDC panel is reconsidering the birth dose for the hepatitis B vaccine. Renewed doubt could lead to fewer kids getting ...

The CDC's vaccine advisory committee is set to meet Thursday and Friday to discuss the childhood vaccine schedule, adjuvants ...

Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today, and they could vote on possible changes to the childhood vaccination schedule. Follow here for live updates ...